Procter & Gamble's earnings transcript indicates a strong performance in fiscal year 2011, with organic sales growth of 4% and core EPS growth of 8%. The company's guidance for fiscal year 2012 suggests organic sales growth of 3-6% and EPS growth of 6-10%. While the company faces challenges such as commodity cost increases and market growth uncertainty, its diversified portfolio and focus on innovation and productivity improvements position it well for long-term growth. The stock is likely to experience a positive impact in the short term due to the company's solid earnings performance and guidance.

[1]